Major Depressive Disorder Clinical Trials

Trials for Major Depressive Disorder

Study of Electrophysiological Markers of Antidepressants in Major Depressive Disorder

NCT06532604 · NOT YET RECRUITING · N/A

PET Biomarker Study for Antidepressant Response Prediction in Major Depressive Disorder

NCT06452290 · NOT YET RECRUITING · N/A

Clinical Efficacy of Intradermal Acupuncture as an Adjunct to SSRI Dose Reduction or Discontinuation in Patients With Major Depressive Disorder and Its Mechanisms of Autonomic Nervous System Regulation

NCT07390981 · NOT YET RECRUITING · N/A

Efficacy and Safety of Low-dose Laser Acupuncture on Treating Insomnia Associated With Major Depressive Disorder: A Randomised Controlled Trial

NCT06443242 · NOT YET RECRUITING · N/A

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder

NCT06633016 · RECRUITING · Phase 2

Randomized Multicenter Clinical Trial of the Efficacy of a Telemedicine Monitoring in the Management of a Depressive Episode After an Hospitalisation in Medicine or Surgery

NCT06076317 · RECRUITING · N/A

A Phase 2a Study to Evaluate the Safety and Tolerability of Two Repeated Doses of GM-2505 at a 2-Week Interval in Patients With Major Depressive Disorder.

NCT06236880 · RECRUITING · Phase 2

31P-MRS and Resting State Functional Connectivity Analysis of the Effects of 5-hydroxytryptophan and Creatine for Antidepressant Augmentation in Patients With SSRI/SNRI-resistant Major Depressive Disorder

NCT05895747 · RECRUITING · Phase 2

The Efficacy of Statins in Management of Major Depression Disorder (MDD) Among Adult Patients Attending the Outpatient Clinics of El Demerdash Hospital.

NCT06698666 · RECRUITING · Phase 3

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-arm Trial to Assess the Efficacy, Safety, and Tolerability of Centanafadine Extended-release Capsules as Monotherapy or as Adjunct to SSRI in Adult Subjects With Major Depressive Disorder

NCT05536414 · COMPLETED · Phase 2

Pilot Randomized Feasibility Trial of Tele-Interpersonal Psychotherapy and Tele-Pharmacotherapy for Depression in Patients With Non-Metastatic Breast Cancer

NCT04973930 · SUSPENDED · Phase 3

The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients: A Proof-of-Concept, Randomized, Double-Blind, Placebo-Controlled Trial

NCT04410341 · WITHDRAWN · Phase 2

Neurosteroid Metabolism and the Antidepressant Effects of Serotonin Specific Reuptake Inhibitors (SSRI's)

NCT00285935 · COMPLETED · N/A

Find More Trials